Evaluating biomarkers for treating Anorexia Nervosa
Official title: Novel Targetable BIOmarkers in ANorexia NervosA - BIOANNA
Run by University Hospital, Basel, Switzerland · NCT05885724 · Data updated 2026-11-12
This study is testing if certain biological markers in people with restrictive Anorexia Nervosa can help find better treatment options by comparing them to healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | April 30, 2025 |
| Study ends | April 30, 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT05885724 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-60 with a confirmed diagnosis of restrictive Anorexia Nervosa and a BMI between 10-16 kg/m2.
✕Probably not a fit
Patients with severe chronic diseases other than Anorexia Nervosa or those who have used antibiotics recently may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the levels of Growth Differentiation Factor-15 (GDF-15) and inflammatory cytokines in patients diagnosed with restrictive Anorexia Nervosa, both exercising and non-exercising subtypes. By comparing these levels in patients to those in healthy controls, the study seeks to identify potential biological targets for treatment. Additionally, body composition and energy expenditure will be measured to correlate these biomarkers with physical health metrics. The findings may pave the way for more individualized treatment approaches for Anorexia Nervosa.
Why it matters
Potential benefit: If successful, this study could lead to novel biological treatments for Anorexia Nervosa, improving patient outcomes.
How similar studies have gone: While the approach of targeting biological markers in Anorexia Nervosa is relatively novel, similar studies in other conditions have shown promise in identifying effective treatments.
Who can join: the full rules
Show full inclusion / exclusion criteria
N=8 adult male and female patients with confirmed diagnosis of anorexia nervosa restrictive type, non-exercising subtype Inclusion criteria: * Age 18-60 years * Written informed consent * BMI 10-16 kg/m2 N=8 adult male and female patients with confirmed diagnosis of anorexia nervosa restrictive type, exercising subtype will be included in this study. Inclusion criteria: * Age 18-60 years * Written informed consent * BMI 10-16 kg/m2 N=16 control participants, sex- and age-matched to the individual anorexia nervosa patients. Inclusion criteria: * Age 18-60 years * Written informed consent * BMI 19-24.9 kg/m2 Exclusion Criteria: * Use of antibiotics within the last 31 days * Current illicit drug abuse including daily marijuana or CBD (cannabidiol) consumption (≤ 24 g of alcohol per day allowed) * Any kind of severe chronic disease other than AN (e.g. active cancer disease) * Severe renal impairment (e.g. estimated glomerular filtration rate \<30 ml/min/m2) if resulting from another disease than AN * Known liver cirrhosis or other severe liver impairment if resulting from another disease than AN * Acute upper respiratory tract infection within the last 31 days * Uncontrolled dysthyroidism * Uncontrolled hypertension * Current pregnancy/lactation or current treatment for in vitro fertilization * Inability to understand the study information, to sign the consent form and to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
Where it's running
-
University Hospital Basel
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Katharina Timper, Prof. — University Hospital, Basel, Switzerland
- Study coordinator: Katharina Timper, Prof.
- Email: katharina.timper@usb.ch
- Phone: +41613285742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Specialist Supportive Clinical Management for teens with anorexia or atypical anorexia
This study tests a teen-focused SSCM approach to help 13-17 year-olds with anorexia nervosa or atypical anorexia nervosa when other treatments haven’t worked or can’t be used.
-
Identifying Signatures of Gut Interoception in Functional Dyspepsia and Anorexia Nervosa
This study tests how the gut-brain connection works in people with functional dyspepsia or anorexia nervosa using brain imaging.
-
Online FBT-DBT for Caregivers of Teens with Anorexia Nervosa
This online program tests a combination of family-based and DBT skills to help caregivers of teens with anorexia nervosa manage stress and improve family support.
-
Eating Disorder Dynamic Intervention
A digital program is tested to help adults with eating disorders by sending real-time, personalized coping tips based on smartphone surveys and sensor data.
-
Hormone and metabolic patterns in hypothalamus-like brain cells from people with anorexia nervosa
This study will test whether hypothalamic-like neurons made from adult women with long-standing anorexia nervosa respond differently to metabolic hormones than neurons from healthy women.
-
Narrative medicine workshops to support teens and young adults with anorexia nervosa (virtual)
This program tests whether a six-week series of narrative medicine workshops can help 16–25-year-olds with anorexia nervosa express themselves, reflect, and build resilience.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.